Drug Shortage Report for SANDOZ DEFERASIROX (TYPE J)

Last updated on 2025-04-22 History
Report ID 243843
Drug Identification Number 02489910
Brand name SANDOZ DEFERASIROX (TYPE J)
Common or Proper name SANDOZ DEFERASIROX (TYPE J)
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) DEFERASIROX
Strength(s) 360MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30FCT
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-11-25
Estimated end date 2025-04-18
Actual end date 2025-04-21
Shortage status Resolved
Updated date 2025-04-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2025-04-22 French Compare
v12 2025-04-22 English Compare
v11 2025-04-07 French Compare
v10 2025-04-07 English Compare
v9 2025-03-03 French Compare
v8 2025-03-03 English Compare
v7 2024-12-10 French Compare
v6 2024-12-10 English Compare
v5 2024-12-10 French Compare
v4 2024-12-10 English Compare
v3 2024-11-26 English Compare
v2 2024-11-25 French Compare
v1 2024-11-25 English Compare

Showing 1 to 13 of 13